Update on anticytokine treatment for asthma

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Gallelli, Luca ^a   Busceti, Maria Teresa ^a   Vatrella, Alessandro ^b   Maselli, Rosario ^a   Pelaia, Girolamo ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ALTRAKINCEPT; ANTIASTHMATIC AGENT; BENRALIZUMAB; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRODALUMAB; CORTICOSTEROID; CYTOKINE ANTIBODY; DUPILUMAB; ETANERCEPT; GOLIMUMAB; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; INFLIXIMAB; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; INTERLEUKIN 5; LEBRIKIZUMAB; MEPOLIZUMAB; PASCOLIZUMAB; PITRAKINRA; PLACEBO; PROTEIN; RESLIZUMAB; SECUKINUMAB; TOLL LIKE RECEPTOR; TRALOKINUMAB; TRFK 5; UNCLASSIFIED DRUG; BIOLOGICAL PRODUCT; CYTOKINE;

ALLERGIC ASTHMA; ANTIGEN RECOGNITION; ASTHMA; B CELL LYMPHOMA; BASAL CELL CARCINOMA; BREAST CANCER; CHRONIC INFLAMMATION; CLINICAL FEATURE; COLON CANCER; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FORCED EXPIRATORY VOLUME; HUMAN; KIDNEY CARCINOMA; MELANOMA; NONHUMAN; PNEUMONIA; REVIEW; SEPSIS; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS; UTERINE CERVIX CARCINOMA; ANIMAL; ANTAGONISTS AND INHIBITORS; METABOLISM; PATHOLOGY; DRUG ANTAGONISM;

ANIMALS; ASTHMA; BIOLOGICAL PRODUCTS; CYTOKINES; HUMANS;

EID: 84880145696     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/104315     Document Type: Review

References (101)

1. Holgate S. T., Arshad H. S., Roberts G. C., Howarth P. H., Thurner P., Davies D. E., A new look at the pathogenesis of asthma. Clinical Science 2010 118 7 439 450 2-s2.0-74749084658 10.1042/CS20090474
2. Anderson G. P., Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. The Lancet 2008 372 9643 1107 1119 2-s2.0-52049087356 10.1016/S0140-6736(08)61452-X
3. Anandan C., Nurmatov U., Van Schayck O. C. P., Sheikh A., Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy 2010 65 2 152 167 2-s2.0-73549109887 10.1111/j.1398-9995.2009.02244.x
4. Masoli M., Fabian D., Holt S., Beasley R., The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy 2004 59 5 469 478 2-s2.0-2342590065 10.1111/j.1398-9995.2004.00526.x
5. Bateman E. D., Boushey H. A., Bousquet J., Busse W. W., Clark T. J. H., Pauwels R. A., Pedersen S. E., Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. American Journal of Respiratory and Critical Care Medicine 2004 170 8 836 844 2-s2.0-5144221336 10.1164/rccm.200401- 033OC
6. Fanta C. H., Asthma. The New England Journal of Medicine 2009 360 10 1002 1014 2-s2.0-61849130565 10.1056/NEJMra0804579
7. Boulet L.-P., Influence of comorbid conditions on asthma. European Respiratory Journal 2009 33 4 897 906 2-s2.0-63849312387 10.1183/09031936. 00121308
8. Daoui S., D'Agostino B., Gallelli L., Alt X. E., Rossi F., Advenier C., Tachykinins and airway microvascular leakage induced by HCI intra-oesophageal instillation. European Respiratory Journal 2002 20 2 268 273 2-s2.0-0035989762 10.1183/09031936.02.00250902
9. Gallelli L., D'Agostino B., Marrocco G., De Rosa G., Filippelli W., Rossi F., Advenier C., Role of tachykinins in the bronchoconstriction induced by HCl intraesophageal instillation in the rabbit. Life Sciences 2003 72 10 1135 1142 2-s2.0-0037462283 10.1016/S0024-3205(02)02372-X
10. D'Agostino B., Marrocco G., De Nardo M., Calò G., Guerrini R., Galleli L., Advenier C., Rossi F., Activation of the nociceptin/orphanin FQ receptor reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux. British Journal of Pharmacology 2005 144 6 813 820 2-s2.0-17144408741 10.1038/sj.bjp.0706066
11. Dolan C. M., Fraher K. E., Bleecker E. R., Borish L., Chipps B., Hayden M. L., Weiss S., Zheng B., Johnson C., Wenzel S., Design and baseline characteristics of The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Annals of Allergy, Asthma and Immunology 2004 92 1 32 39 2-s2.0-9144268928
12. Pelaia G., Vatrella A., Gallelli L., Renda T., Cazzola M., Maselli R., Marsico S. A., Respiratory infections and asthma. Respiratory Medicine 2006 100 5 775 784 2-s2.0-33645887504 10.1016/j.rmed.2005.08.025
13. Barnes P. J., The cytokine network in asthma and chronic obstructive pulmonary disease. Journal of Clinical Investigation 2008 118 11 3546 3556 2-s2.0-55849148482 10.1172/JCI36130
14. D'Agostino B., Advenier C., De Palma R., Gallelli L., Marrocco G., Abbate G. F., Rossi F., The involvement of sensory neuropeptides in airway hyper-responsiveness in rabbits sensitized and challenged to Parietaria judaica. Clinical and Experimental Allergy 2002 32 3 472 479 2-s2.0-0036230403 10.1046/j.1365-2222.2002.01328.x
15. Pelaia G., Cuda G., Vatrella A., Gallelli L., Caraglia M., Marra M., Abbruzzese A., Caputi M., Maselli R., Costanzo F. S., Marsico S. A., Mitogen-activated protein kinases and asthma. Journal of Cellular Physiology 2005 202 3 642 653 2-s2.0-19944432162 10.1002/jcp.20169
16. Pelaia G., Vatrella A., Maselli R., The potential of biologics for the treatment of asthma. Nature Reviews Drug Discovery 2012 11 12 958 972
17. Hansbro P. M., Scott G. V., Essilfie A. T., Kim R. Y., Starkey M. R., Nguyen D. H., Allen P. D., Kaiko G. E., Yang M., Horvat J. C., Foster P. S., Th2 cytokine antagonists: potential treatments for severe asthma. Expert Opinion on Investigational Drugs 2013 22 1 49 69
18. Caruso M., Crisafulli E., Demma S., Holgate S., Polosa R., Disabling inflammatory pathways with biologics and resulting clinical outcomes in severe asthma. Expert Opinion on Biological Therapy 2013 13 3 393 402
19. Pelaia G., Gallelli L., Renda T., Romeo P., Busceti M. T., Grembiale R. D., Maselli R., Marsico S. A., Vatrella A., Update on optimal use of omalizumab in management of asthma. Journal Asthma Allergy 2011 4 49 59
20. Pelaia G., Gallelli L., Romeo P., Renda T., Busceti M. T., Proietto A., Grembiale R. D., Marsico S. A., Maselli R., Vatrella A., Omalizumab decreases exacerbation frequency, oral intake of corticosteroids and peripheral blood eosinophils in atopic patients with uncontrolled asthma. International Journal of Clinical Pharmacology and Therapeutics 2011 49 12 713 721 2-s2.0-82655173707 10.5414/CP201586
21. Holt P. G., Sly P. D., Interaction between adaptive and innate immune pathways in the pathogenesis of atopic asthma: operation of a lung/bone marrow axis. Chest 2011 139 5 1165 1171 2-s2.0-79955763980 10.1378/chest.10-2397
22. Murdoch J. R., Lloyd C. M., Chronic inflammation and asthma. Mutation Research 2010 690 1-2 24 39 2-s2.0-77955269402 10.1016/j.mrfmmm.2009.09.005
23. Hammad H., Chieppa M., Perros F., Willart M. A., Germain R. N., Lambrecht B. N., House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nature Medicine 2009 15 4 410 416 2-s2.0-64149087970 10.1038/nm.1946
24. Woodruff P. G., Modrek B., Choy D. F., Jia G., Abbas A. R., Ellwanger A., Koth L. L., Arron J. R., Fahy J. V., T-helper type 2-driven inflammation defines major subphenotypes of asthma. American Journal of Respiratory and Critical Care Medicine 2009 180 5 388 395
25. Lloyd C. M., Dust mites' dirty dealings in the lung. Nature Medicine 2009 15 4 366 367 2-s2.0-64149099035 10.1038/nm0409-366
26. Kitamura K., Takeda K., Koya T., Miyahara N., Kodama T., Dakhama A., Takai T., Hirano A., Tanimoto M., Harada M., Gelfand E. W., Critical role of the Fc receptor γ -chain on APCs in the development of allergen-induced airway hyperresponsiveness and inflammation. Journal of Immunology 2007 178 1 480 488 2-s2.0-33845941979
27. Kallinich T., Beler K. C., Wahn U., Stock P., Hamelmann E., T-cell co-stimulatory molecules: their role in allergic immune reactions. European Respiratory Journal 2007 29 6 1246 1255 2-s2.0-34250216374 10.1183/09031936. 00094306
28. Kaiko G. E., Horvat J. C., Beagley K. W., Hansbro P. M., Immunological decision-making: how does the immune system decide to mount a helper T-cell response? Immunology 2008 123 3 326 338 2-s2.0-38649090061 10.1111/j.1365-2567. 2007.02719.x
29. Liu Y.-J., Thymic stromal lymphopoietin: master switch for allergic inflammation. Journal of Experimental Medicine 2006 203 2 269 273 2-s2.0-33344455022 10.1084/jem.20051745
30. Larché M., Robinson D. S., Kay A. B., The role of T lymphocytes in the pathogenesis of asthma. Journal of Allergy and Clinical Immunology 2003 111 3 450 463 2-s2.0-0037338904 10.1067/mai.2003.169
31. Fulkerson P. C., Rothenberg M. E., Targeting eosinophils in allergy, inflammation and beyond. Nature Reviews Drug Discovery 2013 12 2 117 129
32. Kaiko G. E., Foster P. S., New insights into the generation of Th2 immunity and potential therapeutic targets for the treatment of asthma. Current Opinion in Allergy and Clinical Immunology 2011 11 1 39 45 2-s2.0-78650804976 10.1097/ACI.0b013e328342322f
33. Cosmi L., Liotta F., Maggi E., Romagnani S., Annunziato F., Th17 cells: new players in asthma pathogenesis. Allergy 2011 66 8 989 998 2-s2.0-79959937269 10.1111/j.1398-9995.2011.02576.x
34. Aujla S. J., Alcorn J. F., T H 17 cells in asthma and inflammation. Biochimica et Biophysica Acta 2011 1810 11 1066 1079 2-s2.0-80054906310 10.1016/j.bbagen.2011.02.002
35. Al-Ramli W., Préfontaine D., Chouiali F., Martin J. G., Olivenstein R., Lemière C., Hamid Q., T H 17-associated cytokines (IL-17A and IL-17F) in severe asthma. Journal of Allergy and Clinical Immunology 2009 123 5 1185 1187 2-s2.0-67349203306 10.1016/j.jaci.2009.02.024
36. Durrant D. M., Metzger D. W., Emerging roles of T helper subsets in the pathogenesis of asthma. Immunological Investigations 2010 39 4-5 526 549 2-s2.0-77952128925 10.3109/08820131003615498
37. Zhao Y., Yang J., Gao Y.-D., Guo W., Th17 immunity in patients with allergic asthma. International Archives of Allergy and Immunology 2010 151 4 297 307 2-s2.0-70350041508 10.1159/000250438
38. Lukacs N. W., Strieter R. M., Chensue S. W., Widmer M., Kunkel S. L., TNF- α mediates recruitment of neutrophils and eosinophils during airway inflammation. Journal of Immunology 1995 154 10 5411 5417 2-s2.0-0028989599
39. Amrani Y., Panettieri R. A. Jr., Frossard N., Bronner C., Activation of the TNF α -p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells. American Journal of Respiratory Cell and Molecular Biology 1996 15 1 55 63 2-s2.0-0030192001
40. Dougherty R. H., Fahy J. V., Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype. Clinical and Experimental Allergy 2009 39 2 193 202 2-s2.0-58849162826 10.1111/j.1365-2222.2008.03157.x
41. Contoli M., Message S. D., Laza-Stanca V., Edwards M. R., Wark P. A. B., Bartlett N. W., Kebadze T., Mallia P., Stanciu L. A., Parker H. L., Slater L., Lewis-Antes A., Kon O. M., Holgate S. T., Davies D. E., Kotenko S. V., Papi A., Johnston S. L., Role of deficient type III interferon- production in asthma exacerbations. Nature Medicine 2006 12 9 1023 1026 2-s2.0-33748446393 10.1038/nm1462
42. + T cells is associated with the phenotypes of allergic asthma. Respirology 2009 14 2 187 194 2-s2.0-61349156740 10.1111/j.1440-1843.2008.01472.x
43. Provoost S., Maes T., Van Durme Y. M., Gevaert P., Bachert C., Schmidt-Weber C. B., Brusselle G. G., Joos G. F., Tournoy K. G., Decreased FOXP3 protein expression in patients with asthma. Allergy 2009 64 10 1539 1546 2-s2.0-70349200850 10.1111/j.1398-9995.2009.02056.x
44. Lloyd C. M., Hessel E. M., Functions of T cells in asthma: more than just T H 2 cells. Nature Reviews Immunology 2010 10 12 838 848 2-s2.0-78649516124 10.1038/nri2870
45. Barnes P. J., Intrinsic asthma: not so different from allergic asthma but driven by superantigens? Clinical and Experimental Allergy 2009 39 8 1145 1151 2-s2.0-67650418178 10.1111/j.1365-2222.2009.03298.x
46. Turato G., Barbato A., Baraldo S., Zanin M. E., Bazzan E., Lokar-Oliani K., Calabrese F., Panizzolo C., Snijders D., Maestrelli P., Zuin R., Fabbri L. M., Saetta M., Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma. American Journal of Respiratory and Critical Care Medicine 2008 178 5 476 482 2-s2.0-51349131997 10.1164/rccm.200712-1818OC
47. Bergeron C., Al-Ramli W., Hamid Q., Remodeling in asthma. Proceedings of the American Thoracic Society 2009 6 3 301 305 2-s2.0-67049155288 10.1513/pats.200808-089RM
48. Holgate S. T., Holloway J., Wilson S., Bucchieri F., Puddicombe S., Davies D. E., Epithelial-mesenchymal communication in the pathogenesis of chronic asthma. Proc Am Thorac Soc 2004 1 2 93 98 2-s2.0-14944365805
49. Hackett T.-L., Warner S. M., Stefanowicz D., Shaheen F., Pechkovsky D. V., Murray L. A., Argentieri R., Kicic A., Stick S. M., Bai T. R., Knight D. A., Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor- β 1. American Journal of Respiratory and Critical Care Medicine 2009 180 2 122 133 2-s2.0-67650752133 10.1164/rccm.200811-1730OC
50. D'Agostino B., Gallelli L., Falciani M., Di Pierro P., Rossi F., Filippelli A., Rossi F., Endothelin-1 induced bronchial hyperresponsiveness in the rabbit: an ET(A) receptor-mediated phenomenon. Naunyn-Schmiedeberg's Archives of Pharmacology 1999 360 6 665 669 2-s2.0-0033401320 10.1007/s002109900146
51. Rossi F., Gallelli L., Marrocco G., Capristo C., Del Giudice M. M., Decimo F., Brunese F. P., Capristo A. F., D'Agostino B., Ruolo dell'endotelina nell'apparato respiratorio. Minerva Pneumologica 2000 39 111 122
52. D'Agostino B., Advenier C., Falciani M., Gallelli L., Marrocco G., Piegari E., Filippelli A., Rossi F., Endothelin-1 increases cholinergic nerve-mediated contraction of human bronchi via tachykinin synthesis induction. British Journal of Pharmacology 2001 134 7 1447 1454 2-s2.0-0035206680
53. Gallelli L., Pelaia G., D'Agostino B., Cuda G., Vatrella A., Fratto D., Gioffrè V., Galderisi U., De Nardo M., Mastruzzo C., Salinaro E. T., Maniscalco M., Sofia M., Crimi N., Rossi F., Caputi M., Costanzo F. S., Maselli R., Marsico S. A., Vancheri C., Endothelin-1 induces proliferation of human lung fibroblasts and IL-11 secretion through an ETA receptor-dependent activation of map kinases. Journal of Cellular Biochemistry 2005 96 4 858 868 2-s2.0-27644462685 10.1002/jcb.20608
54. Pelaia G., Gallelli L., D'Agostino B., Vatrella A., Cuda G., Fratto D., Renda T., Galderisi U., Piegari E., Crimi N., Rossi F., Caputi M., Costanzo F. S., Vancheri C., Maselli R., Marsico S. A., Effects of TGF- β and glucocorticoids on map kinase phosphorylation, IL-6/IL-11 secretion and cell proliferation in primary cultures of human lung fibroblasts. Journal of Cellular Physiology 2007 210 2 489 497 2-s2.0-33845670432 10.1002/jcp.20884
55. D'Agostino B., Roviezzo F., De Palma R., Terracciano S., De Nardo M., Gallelli L., Abbate G. F., D'Aiuto E., Russo M., Cirino G., Rossi F., Activation of protease-activated receptor-2 reduces airways inflammation in experimental allergic asthma. Clinical and Experimental Allergy 2007 37 10 1436 1443 2-s2.0-34648846307 10.1111/j.1365-2222.2007.02793.x
56. Gallelli L., Falcone D., Pelaia G., Renda T., Terracciano R., Malara N., Vatrella A., Sanduzzi A., D'Agostino B., Rossi F., Vancheri C., Maselli R., Marsico S. A., Savino R., Interleukin-6 receptor superantagonist Sant7 inhibits TGF- β -induced proliferation of human lung fibroblasts. Cell Proliferation 2008 41 3 393 407 2-s2.0-43749119554 10.1111/j.1365-2184.2008.00538.x
57. Pelaia G., Renda T., Gallelli L., Vatrella A., Busceti M. T., Agati S., Caputi M., Cazzola M., Maselli R., Marsico S. A., Molecular mechanisms underlying airway smooth muscle contraction and proliferation: implications for asthma. Respiratory Medicine 2008 102 8 1173 1181 2-s2.0-47249158885 10.1016/j.rmed.2008.02.020
58. Holgate S. T., Pathophysiology of asthma: what has our current understanding taught us about new therapeutic approaches? Journal of Allergy and Clinical Immunology 2011 128 3 495 505 2-s2.0-80052272692 10.1016/j.jaci.2011. 06.052
59. Garlisi C. G., Kung T. T., Wang P., Minnicozzi M., Umland S. P., Chapman R. W., Stelts D., Crawley Y., Falcone A., Myers J. G., Jones H., Billah M. M., Kreutner W., Egan R. W., Effects of chronic anti-interleukin-5 monoclonal antibody treatment in a murine model of pulmonary inflammation. American Journal of Respiratory Cell and Molecular Biology 1999 20 2 248 255 2-s2.0-0033070962
60. Mauser P. J., Pitman A. M., Fernandez X., Foran S. K., Adams G. K. III, Kreutner W., Egan R. W., Chapman R. W., Effects of an antibody to interleukin-5 in a monkey model of asthma. American Journal of Respiratory and Critical Care Medicine 1995 152 2 467 472 2-s2.0-0029146701
61. Molfino N. A., Gossage D., Kolbeck R., Parker J. M., Geba G. P., Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor. Clinical and Experimental Allergy 2012 42 5 712 737 2-s2.0-84860010929 10.1111/j.1365-2222.2011.03854.x
62. Leckie M. J., Ten Brinke A., Khan J., Diamant Z., O'Connor B. J., Walls C. M., Mathur A. K., Cowley H. C., Chung K. F., Djukanovic R., Hansel T. T., Holgate S. T., Sterk P. J., Barnes P. J., Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000 356 2144 2148 2-s2.0-6644229440 10.1016/S0140-6736(00)03496-6
63. Flood-Page P., Swenson C., Faiferman I., Matthews J., Williams M., Brannick L., Robinson D., Wenzel S., Busse W., Hansel T. T., Barnes N. C., A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. American Journal of Respiratory and Critical Care Medicine 2007 176 11 1062 1071 2-s2.0-36749065556 10.1164/rccm.200701-085OC
64. Haldar P., Brightling C. E., Hargadon B., Gupta S., Monteiro W., Sousa A., Marshall R. P., Bradding P., Green R. H., WardIaw A. J., Pavord I. D., Mepolizumab and exacerbations of refractory eosinophilic asthma. The New England Journal of Medicine 2009 360 10 973 984 2-s2.0-61849086181 10.1056/ NEJMoa0808991
65. Nair P., Pizzichini M. M. M., Kjarsgaard M., Inman M. D., Efthimiadis A., Pizzichini E., Hargreave F. E., O'Byrne P. M., Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. The New England Journal of Medicine 2009 360 10 985 993 2-s2.0-61849155730 10.1056/NEJMoa0805435
66. Pavord I. D., Korn S., Howarth P., Bleecker E. R., Buhl R., Keene O. N., Ortega H., Chanez P., Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 2012 380 9842 651 659
67. Castro M., Mathur S., Hargreave F., Boulet L.-P., Xie F., Young J., Jeffrey Wilkins H., Henkel T., Nair P., Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. American Journal of Respiratory and Critical Care Medicine 2011 184 10 1125 1132 2-s2.0-81455155725 10.1164/rccm.201103-0396OC
68. Busse W. W., Katial R., Gossage D., Sari S., Wang B., Kolbeck R., Coyle A. J., Koike M., Spitalny G. L., Kiener P. A., Geba G. P., Molfino N. A., Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor α antibody, in a phase I study of subjects with mild asthma. Journal of Allergy and Clinical Immunology 2010 125 6 1237 1244 2-s2.0-77952683218 10.1016/j.jaci.2010.04.005
69. Oh C. K., Geba G. P., Molfino N., Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma. European Respiratory Review 2010 19 115 46 54 2-s2.0-77649198441 10.1183/09059180.00007609
70. Coyle A. J., Le Gros G., Bertrand C., Tsuyuki S., Heusser C. H., Kopf M., Anderson G. P., Interleukin-4 is required for the induction of lung Th2 mucosal immunity. American journal of respiratory cell and molecular biology 1995 13 1 54 59 2-s2.0-0029335074
71. Swart D. A., Anders-Bartholo P. M., Tocker J. E., Effects of IL-4R α blockade on lung inflammation and airway hyperresponsiveness using Mu317RAXMu, a murine surrogate for AMG 317, in a treatment model of cockroach allergen-induced asthma in mice. Journal of Allergy and Clinical Immunology 2008 121 2 S267
72. Steinke J. W., Anti-interleukin-4 therapy. Immunology and Allergy Clinics of North America 2004 24 4 599 614 2-s2.0-4944239352 10.1016/j.iac.2004.06.008
73. Burmeister Getz E., Fisher D. M., Fuller R., Human pharmacokinetics/ pharmacodynamics of an interleukin-4 and interleukin-13 dual antagonist in asthma. Journal of Clinical Pharmacology 2009 49 9 1025 1036 2-s2.0-69549129344 10.1177/0091270009341183
74. Wenzel S., Wilbraham D., Fuller R., Getz E. B., Longphre M., Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet 2007 370 9596 1422 1431 2-s2.0-35348909044 10.1016/S0140-6736(07)61600-6
75. Slager R. E., Otulana B. A., Hawkins G. A., Yen Y. P., Peters S. P., Wenzel S. E., Meyers D. A., Bleecker E. R., IL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti-IL-4 receptor α antagonist. Journal of Allergy and Clinical Immunology 2012 130 2 516 522 2-s2.0-84860124436 10.1016/j.jaci.2012.03.030
76. Wenzel S., Ford L., Pearlman D., Spector S., Sher L., Skobieranda F., Wang L., Kirkesseli S., Rocklin R., Bock B., Hamilton J., Ming J. E., Radin A., Stahl N., Yancopoulos G. D., Graham N., Pirozzi G., Dupilumab in persistent asthma with elevated eosinophil levels. The New England Journal of Medicine 2013 10.1056/NEJMoa1304048
77. Gauvreau G. M., Boulet L.-P., Cockcroft D. W., Fitzgerald J. M., Carlsten C., Davis B. E., Deschesnes F., Duong M., Durn B. L., Howie K. J., Hui L., Kasaian M. T., Killian K. J., Strinich T. X., Watson R. M., Nathalie Y., Zhou S., Raible D., O'Byrne P. M., Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. American Journal of Respiratory and Critical Care Medicine 2011 183 8 1007 1014 2-s2.0-79954583416 10.1164/rccm.201008-1210OC
78. Corren J., Lemanske R. F. Jr., Hanania N. A., Korenblat P. E., Parsey M. V., Arron J. R., Harris J. M., Scheerens H., Wu L. C., Su Z., Mosesova S., Eisner M. D., Bohen S. P., Matthews J. G., Lebrikizumab treatment in adults with asthma. The New England Journal of Medicine 2011 365 12 1088 1098 2-s2.0-80053084755 10.1056/NEJMoa1106469
79. Oh C. K., Faggioni R., Jin F., Roskos L. K., Wang B., Birrell C., Wilson R., Molfino N. A., An open-label, single-dose bioavailability study of the pharmacokinetics of CAT-354 after subcutaneous and intravenous administration in healthy males. British Journal of Clinical Pharmacology 2010 69 6 645 655 2-s2.0-77952022559 10.1111/j.1365-2125.2010.03647.x
80. Piper E., Brightling C., Niven R., Oh C., Faggioni R., Poon K., She D., Kell C., May R. D., Geba G. P., Molfino N. A., A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma. European Respiratory Journal 2013 41 2 330 338
81. Oh C. K., Raible D., Geba G. P., Molfino N. A., Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthma. Inflammation and Allergy 2011 10 3 180 186 2-s2.0-79958219647
82. Cheng G., Arima M., Honda K., Hirata H., Eda F., Yoshida N., Fukushima F., Ishii Y., Fukuda T., Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. American Journal of Respiratory and Critical Care Medicine 2002 166 3 409 416 2-s2.0-0036683621 10.1164/rccm.2105079
83. Parker J. M., Oh C. K., LaForce C., Miller S. D., Pearlman D. S., Le C., Robbie G. J., White W. I., White B., Molfino N. A., Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma. BMC Pulmonary Medicine 2011 11 article 14 2-s2.0-79952049626 10.1186/1471-2466-11-14
84. Yamashita N., Tashimo H., Ishida H., Kaneko F., Nakano J., Kato H., Hirai K., Horiuchi T., Ohta K., Attenuation of airway hyperresponsiveness in a murine asthma model by neutralization of granulocyte-macrophage colony-stimulating factor (GM-CSF). Cellular Immunology 2002 219 2 92 97 2-s2.0-0036826485 10.1016/S0008-8749(02)00565-8
85. Krinner E.-M., Raum T., Petsch S., Bruckmaier S., Schuster I., Petersen L., Cierpka R., Abebe D., Mølhøj M., Wolf A., Sørensen P., Locher M., Baeuerle P. A., Hepp J., A human monoclonal IgG1 potently neutralizing the pro-inflammatory cytokine GM-CSF. Molecular Immunology 2007 44 5 916 925 2-s2.0-33748800252 10.1016/j.molimm.2006.03.020
86. Brightling C., Berry M., Amrani Y., Targeting TNF- α: a novel therapeutic approach for asthma. Journal of Allergy and Clinical Immunology 2008 121 1 5 10 2-s2.0-38149091442 10.1016/j.jaci.2007.10.028
87. Berry M. A., Hargadon B., Shelley M., Parker D., Shaw D. E., Green R. H., Bradding P., Brightling C. E., Wardlaw A. J., Pavord I. D., Evidence of a role of tumor necrosis factor α in refractory asthma. The New England Journal of Medicine 2006 354 7 697 708 2-s2.0-32644490529 10.1056/NEJMoa050580
88. Holgate S. T., Noonan M., Chanez P., Busse W., Dupont L., Pavord I., Hakulinen A., Paolozzi L., Wajdula J., Zang C., Nelson H., Raible D., Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial. European Respiratory Journal 2011 37 6 1352 1359 2-s2.0-79957987328 10.1183/09031936.00063510
89. Erin E. M., Leaker B. R., Nicholson G. C., Tan A. J., Green L. M., Neighbor H., Zacharasiewicz A. S., Turner J., Barnathan E. S., Kon O. M., Barnes P. J., Hansel T. T., The effects of a monoclonal antibody directed against tumor necrosis factor- α in asthma. American Journal of Respiratory and Critical Care Medicine 2006 174 7 753 762
90. Wenzel S. E., Barnes P. J., Bleecker E. R., Bousquet J., Busse W., Dahlén S.-E., Holgate S. T., Meyers D. A., Rabe K. F., Antczak A., Baker J., Horvath I., Mark Z., Bernstein D., Kerwin E., Schlenker-Herceg R., Lo K. H., Watt R., Barnathan E. S., Chanez P., A randomized, double-blind, placebo-controlled study of tumor necrosis factor- α blockade in severe persistent asthma. American Journal of Respiratory and Critical Care Medicine 2009 179 7 549 558 2-s2.0-62549084077 10.1164/rccm.200809-1512OC
91. Hellings P. W., Kasran A., Liu Z., Vandekerckhove P., Wuyts A., Overbergh L., Mathieu C., Ceuppens J. L., Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. American Journal of Respiratory Cell and Molecular Biology 2003 28 1 42 50 2-s2.0-0037216818 10.1165/rcmb.4832
92. Wakashin H., Hirose K., Maezawa Y., Kagami S.-I., Suto A., Watanabe N., Saito Y., Hatano M., Tokuhisa T., Iwakura Y., Puccetti P., Iwamoto I., Nakajima H., IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. American Journal of Respiratory and Critical Care Medicine 2008 178 10 1023 1032 2-s2.0-57349084248 10.1164/rccm.200801-086OC
93. Park S. J., Lee Y. C., Interleukin-17 regulation: an attractive therapeutic approach for asthma. Respiratory Research 2010 11 article 78 2-s2.0-77956671917 10.1186/1465-9921-11-78
94. Tamachi T., Maezawa Y., Ikeda K., Kagami S.-I., Hatano M., Seto Y., Suto A., Suzuki K., Watanabe N., Saito Y., Tokuhisa T., Iwamoto I., Nakajima H., IL-25 enhances allergic airway inflammation by amplifying a T H 2 cell-dependent pathway in mice. Journal of Allergy and Clinical Immunology 2006 118 3 606 614 2-s2.0-33748064320 10.1016/j.jaci.2006.04.051
95. Kearley J., Buckland K. F., Mathie S. A., Lloyd C. M., Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. American Journal of Respiratory and Critical Care Medicine 2009 179 9 772 781 2-s2.0-65549152797 10.1164/rccm.200805-666OC
96. Fujita J., Kawaguchi M., Kokubu F., Ohara G., Ota K., Huang S.-K., Morishima Y., Ishii Y., Satoh H., Sakamoto T., Hizawa N., Interleukin-33 induces interleukin-17F in bronchial epithelial cells. Allergy 2012 67 6 744 750 2-s2.0-84860215236 10.1111/j.1398-9995.2012.02825.x
97. Shi L., Leu S.-W., Xu F., Zhou X., Yin H., Cai L., Zhang L., Local blockade of TSLP receptor alleviated allergic disease by regulating airway dendritic cells. Clinical Immunology 2008 129 2 202 210 2-s2.0-53749105022 10.1016/j.clim.2008.07.015
98. Li J. J., Wang W., Baines K. J., Bowden N. A., Hansbro P. M., Gibson P. G., Kumar R. K., Foster P. S., Yang M., IL-27/IFN- γ induce MyD88-dependent steroid-resistant airway hyperresponsiveness by inhibiting glucocorticoid signaling in macrophages. Journal of Immunology 2010 185 7 4401 4409 2-s2.0-77958117957 10.4049/jimmunol.1001039
99. Jacobsen E. A., Helmers R. A., Lee J. J., Lee N. A., The expanding role(s) of eosinophils in health and disease. Blood 2012 120 19 3882 3890
100. Fabre V., Beiting D. P., Bliss S. K., Gebreselassie N. G., Gagliardo L. F., Lee N. A., Lee J. J., Appleton J. A., Eosinophil deficiency compromises parasite survival in chronic nematode infection. Journal of Immunology 2009 182 3 1577 1583 2-s2.0-63149136492
101. Gebreselassie N. G., Moorhead A. R., Fabre V., Gagliardo L. F., Lee N. A., Lee J. J., Appleton J. A., Eosinophils preserve parasitic nematode larvae by regulating local immunity. Journal of Immunology 2012 188 1 417 425 2-s2.0-84855384507 10.4049/jimmunol.1101980